ANXA2P2
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| annexin A2 pseudogene 2 | HGNC:HGNC:539 | PA24829 | 9p13.3 |
Gene Categories:
PHOSPHOLIPASEGO terms in ANXA2P2
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IEA | GO:0004859 | phospholipase inhibitor activity |
| MF | IEA | GO:0005509 | calcium ion binding |
| MF | IEA | GO:0005544 | calcium-dependent phospholipid binding |
| MF | IEA | GO:0008092 | cytoskeletal protein binding |
| CC | IEA | GO:0005604 | basement membrane |
| CC | IEA | GO:0042470 | melanosome |
| CC | HDA | GO:0070062 | extracellular exosome |
| BP | IEA | GO:0043086 | negative regulation of catalytic activity |
Gene expression in normal tissue: ANXA2P2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ANXA2P2
| Database | Pathway ID | Pathway Des. |
|---|
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in ANXA2P2
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.